Your browser doesn't support javascript.
loading
Effects of compound-326, a selective delta-5 desaturase inhibitor, in ApoE knockout mice with two different protocols for atherosclerosis development.
Nagase, Hiroki; Takagahara, Shuichi; Satomi, Yoshinori; Ando, Ayumi; Kubo, Kazuki; Ikeda, Shota.
Afiliación
  • Nagase H; Cardiovascular and Metabolic Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd. Presntly, R&D Strategy & Management Office, Research Division, SCOHIA PHARMA, Inc.
  • Takagahara S; Cardiovascular and Metabolic Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd.
  • Satomi Y; Integrated Technology Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd.
  • Ando A; Integrated Technology Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd.
  • Kubo K; Cardiovascular and Metabolic Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd.
  • Ikeda S; Cardiovascular and Metabolic Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd.
J Pharm Pharm Sci ; 24: 71-83, 2021.
Article en En | MEDLINE | ID: mdl-33600308
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores Enzimáticos / Aterosclerosis / Ácido Graso Desaturasas Tipo de estudio: Guideline Límite: Animals Idioma: En Revista: J Pharm Pharm Sci Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores Enzimáticos / Aterosclerosis / Ácido Graso Desaturasas Tipo de estudio: Guideline Límite: Animals Idioma: En Revista: J Pharm Pharm Sci Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article